The estimated Net Worth of Management Co Llc Mancheste... is at least $7.85 Million dollars as of 29 August 2014. Management Mancheste owns over 40,600 units of Fennec Pharmaceuticals Inc stock worth over $7,845,153 and over the last 10 years Management sold FENC stock worth over $0.
Management has made over 4 trades of the Fennec Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently Management bought 40,600 units of FENC stock worth $72,268 on 29 August 2014.
The largest trade Management's ever made was buying 189,800 units of Fennec Pharmaceuticals Inc stock on 29 August 2014 worth over $476,398. On average, Management trades about 104,007 units every 0 days since 2014. As of 29 August 2014 Management still owns at least 1,491,474 units of Fennec Pharmaceuticals Inc stock.
You can see the complete history of Management Mancheste stock trades at the bottom of the page.
Over the last 10 years, insiders at Fennec Pharmaceuticals Inc have traded over $13,607,192 worth of Fennec Pharmaceuticals Inc stock and bought 1,966,488 units worth $9,890,813 . The most active insiders traders include Management Pr, Llcmancheste..., Spacavazza Paolo Cavazza En..., and Rosty Raykov. On average, Fennec Pharmaceuticals Inc executives and independent directors trade stock every 69 days with the average trade being worth of $442,734. The most recent stock trade was executed by Rosty Raykov on 31 August 2024, trading 2,431 units of FENC stock currently worth $13,419.
fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.
Fennec Pharmaceuticals Inc executives and other stock owners filed with the SEC include: